Company: APXIF
Filing Date: 2025-06-11
Form Type: 10-Q
Source: 0001213900-25-053185
Chunk: 124

Company: APx Acquisition Corp. I
Filing Date: 2025-06-11
Form: 10-Q
Item: Part I, Item 8
Chunk 124
---
 Combination
Agreement may be terminated and the Transactions may be abandoned at any time prior to the Merger Effective Time, notwithstanding any
requisite approval and adoption of the Business Combination Agreement and the Proposed Business Combination by the shareholders of the
Company, (i) by mutual written consent of OmnigenicsAI and the Company; (ii) by either OmnigenicsAI or the Company if the Merger
Effective Time shall not have occurred prior to 5:00 p.m. (New York time) on December 9, 2024, subject to certain exceptions; (iii) by
either OmnigenicsAI or the Company if any Governmental Authority shall have enacted, issued, promulgated, enforced or entered any injunction,
order, decree or ruling (whether temporary, preliminary or permanent) which has become final and non-appealable and has the
effect of making consummation of the Transactions illegal or otherwise preventing or prohibiting consummation of the Transaction or the
Merger; (iv) by OmnigenicsAI if the SPAC Shareholders’ Approval shall not have been obtained by reason of the failure to obtain
the required vote at the SPAC Shareholders’ Meeting duly convened therefor or at any adjournment thereof; (v) by the Company
upon a breach of any representation, warranty, covenant or agreement set forth in the Business Combination Agreement on the part of OmnigenicsAI
or Merger Sub, subject to certain exceptions and cure periods set forth in the Business Combination Agreement, such that the conditions
relating to representations and warranties and certain covenants and agreements would not be satisfied; (vi) by OmnigenicsAI upon
any breach of any representation, warranty, covenant or agreement set forth in the Business Combination Agreement on the part of the Company,
subject to certain exceptions and cure periods set forth in the Business Combination Agreement, such that the conditions relating to representations
and warranties and certain covenants and agreements would not be satisfied; (vii) by the Company in the event (A) (1) MultiplAI
or any of the MultiplAI Shareholders breaches or violates any representation, warranty, covenant, agreement or obligation contained in
the MultiplAI SPA, subject to certain exceptions and cure periods set forth in the Business Combination Agreement, such that the conditions
relating to representations and warranties and certain covenants and agreements contained in the MultiplAI SPA would not be satisfied